Kanghua Bio (300841): Minsheng Securities Co., Ltd.'s special inspection opinion on Chengdu Kanghua Biological Products Co., Ltd.'s sale of equity to exit the joint investment enterprise of related parties and related transactions- CFi.CN Zhongcai Network

Key Data Concepts:   

? These are the company names, stock quotes, topics, and entities related to this data.

002340 002786 002913 300568 300585 300713 300841 Aoshikang Technology Chengdu Kanghua Biological Products China Shipbuilding Industry Group Power Citic Securities Fujian Funeng Gem Nanjing Aolian Ae&Ea Shenzhen Senior Technology Material Shenzhen Silver Basis Technology Shenzhenrease Technology Xinjiang Sayram Modern Agriculture Crime, Law, Justice Breach Of Contract Litigation Arbitration Law Regulations Buyback Shareholder Management Strategy, Marketing Annual, Special Corporate Meeting Board Of Directors Research, Development Pharmaceutical Wholesale Electricity Production, Distribution Financial, Business Service Automotive Credit, Debt Market, Exchange Securities Medical Equipment Small, Medium Enterprise Cosmetics Economy, Business, Finance

Full Data

?
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on the Chinese Stock Markets

Join Now!

Need this critical market data?

Access thousands of market events, data points, and news articles!

Already have an account?
Login

Home » News » Kanghua Bio (300841): Minsheng Securities Co., Ltd.'s special inspection opinion on Chengdu Kanghua Biological Products Co., Ltd.'s sale of equity to exit the joint investment enterprise of related parties and related transactions- CFi.CN Zhongcai Network